2016, Number 4
<< Back Next >>
Med Int Mex 2016; 32 (4)
Congenital heart disease in pregnant women: an approach for internal medicine physician
Garnica-Camacho CE
Language: Spanish
References: 24
Page: 436-445
PDF size: 664.09 Kb.
ABSTRACT
Congenital heart defects are the most common defects in live births
and at least 85% of them will reach adulthood. Women with these
defects and with a desire to become pregnant should be exposed to a
hemodynamic stress that could affect the integrity of both the mother
and the fetus, therefore, are considered complex situations. There are
certain injuries that are not compatible with pregnancy, so pregnancy
is not advised. That plea forces the internist to know the basic cardiovascular
concepts, support for medical advice, anticipate future
complications in pregnancy, childbirth or postpartum, and know how
to deal with (identifying, diagnosing and managing) specific contexts,
such as heart failure, arrhythmias, anticoagulation and endocarditis,
with no deleterious drugs to the binomial.
REFERENCES
Greutmann M, Pieper PG. Pregnancy in women with congenital heart disease. Eur Heart J 2015 Jun 25. pii: ehv288
Torres-Gómez LG y col. Embarazo y tetralogía de Fallot con y sin corrección quirúrgica. Ginecol Obstet Mex 2010;78:309-315.
Shaline R, Ginns JN. Adult congenital heart disease and pregnancy. Semin Perinatol 2014;38:260-272.
Emmanuel Y, Thorne SA. Heart disease in pregnancy. Best Pract Res Clin Obstet Gynaecol 2015;29:579-597.
Hall ME, et al. El corazón durante el embarazo. Rev Esp Cardiol 2011;64:1045-1050.
Gelson E, et al. Cardiac disease in pregnancy. Part 1: congenital heart disease. Obstet Gynaecol 2007;9:15-20.
Harris IS. Management of pregnancy in patients with congenital heart disease. Prog Cardiovasc Dis 2011;53:305- 311.
Naderi S, Raymond R. Pregnancy and heart disease. Cleveland Clinic (February 2014) from http://www.clevelandclinicmeded. com/medicalpubs/diseasemanagement/ cardiology/pregnancy-and-heart-disease/Default.htm
Davies GAL, Herbert WNP. Heart disease in pregnancy 1. Assessment and management of cardiac disease in pregnancy. J Obstet Gynaecol Can 2007;29:331-336.
Uebing A, et al. Congenital heart disease in pregnancy. Dtsch Arztebl Int 2008;105:347-354.
Presbitero P, et al. Pregnancy in cyanotic congenital heart disease outcome of mother and fetus. Circulation 1994;89.
ESC Guidelines on the management of cardiovascular diseases during pregnancy. Eur Heart J 2011;32:3147-3197.
Drenthen W, Boersma E, Balci A, Moons P, et al. Predictors of pregnancy complications in women with congenital heart disease. Eur Heart J 2010;31:2124-2132.
Khairy P, et al. Pregnancy outcomes in women with congenital heart disease. Circulation 2006;113:517-524.
Gibson P, Powrie R. Anticoagulants and pregnancy: When are they safe? Clev Clin J Med 2009;76.
Shaddy RE, Webb G. Applying heart failure guidelines to adult congenital heart disease patients. Expert Rev Cardiovasc Ther 2008;6:165-174.
Alonso-González R, et al. Ventrículo derecho y cardiopatías congénitas en el adulto. Rev Esp Cardiol 2010;63:1070- 1086.
Alwan S, Polifka JE, Friedman JM. Angiotensin II receptor antagonist treatment during pregnancy. Birth Defects Res A Clin Mol Teratol 2005;73:123.
Easterling TR, Carr DB, Brateng D, et al. Treatment of hypertension in pregnancy: effect of atenolol on maternal disease, preterm delivery, and fetal growth. Obstet Gynecol 2001;98:427.
Wald RM, et al. Pregnancy in young women with congenital heart disease: Lesion-specific considerations. Paediatr Child Health 2011;16.
Gómez Flores JR y col. Arritmias en el embarazo ¿Cómo y cuándo tratar? Arch Cardiol Méx 2007;77.
Adamson DL, Nelson-Piercy C. Managing palpitations and arrhythmias during pregnancy. Heart 2007;93:1630-1636.
Head CEG, Thorne SA. Congenital heart disease in pregnancy. Postgrad Med J 2005;81:292-298.
Ruys TPE, et al. Pregnancy and delivery in cardiac disease. J Cardiol 2013;61:107-112